NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT00791011 2014-03-05Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or VorinostatAmgenPhase 1 Completed33 enrolled